Literature DB >> 2858146

Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method.

H Ording, L T Skovgaard, J Engbaek, J Viby-Mogensen.   

Abstract

The purpose of this study was to compare the incremental, cumulative dose method and the single bolus injection technique for construction of dose-response curves for vecuronium. Dose-response curves were determined in 77 patients divided into four groups according to the anaesthetic given and the method used for construction of dose-response curves. The regression lines corresponding to the four dose-response curves were found to be parallel. For vecuronium ED50 during neurolept anaesthesia was found to be 28 micrograms kg-1 with the single bolus injection technique and 35.2 micrograms kg-1 with the incremental, cumulative dose method (P less than 0.05). During halothane anaesthesia, ED50 was found to be 25.7 micrograms kg-1 and 26.2 micrograms kg-1, respectively (P greater than 0.05). Potentiation of vecuronium by halothane was found with the cumulative method only. It is concluded that the incremental, cumulative dose method is not suitable for potency determinations of vecuronium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858146     DOI: 10.1111/j.1399-6576.1985.tb02171.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

Review 1.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

2.  Efficacy of priming with atracurium.

Authors:  M Sosis
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

3.  Vecuronium is more potent in Montreal than in Paris.

Authors:  P Fiset; F Donati; P Balendran; C Meistelman; E Lira; D R Bevan
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

4.  Nitrous oxide potentiates vecuronium neuromuscular blockade in humans.

Authors:  P Fiset; P Balendran; D R Bevan; F Donati
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

Review 5.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

6.  Sensitivity to vecuronium in myasthenia gravis: a dose-response study.

Authors:  J B Eisenkraft; W J Book; A E Papatestas
Journal:  Can J Anaesth       Date:  1990-04       Impact factor: 5.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.